Cannabis Law Report

JULY 29, 2021

With Avicanna’s dedication to quality standards and pharmaceutical positioning we are poised to be a significant long-term player in the European medical market that is predominantly focused on medical utility of cannabinoids and where meeting EU pharmacopeia standards are essential.”. New progressive regulation on cannabis in Colombia.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

AUGUST 29, 2021

This export also validates the emergence of the global cannabinoid sector with reliance on quality, traceability and sustainability that Avicanna ’s Aureus products offer. To the knowledge of the Company, it carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Cannabis Law Report

AUGUST 11, 2021

(“Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

The Cannigma

MARCH 26, 2021

Later in the show, Matthew discusses the potential for cannabinoids to experience a huge upswing as the industry matures. The key question he asks is whether “THC is popular because it’s the best cannabinoid? Terminology like ‘indica-sativa hybrids.’ Or is THC popular because of a lack of choice?”.

Education 115

Education Cannabinoids Indica Supply Chain 115

The Cannigma

JANUARY 19, 2022

We think now that as more and more data is becoming available, the cannabis could be a very useful treatment both THC and CBD have shown promise in helping with the inflammation and some of the damage that has occurred in the brain. EG: Definitely. Specific strain names, I learned, really mean nothing.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

NOVEMBER 22, 2019

California regulators temporarily suspended the licenses of over 400 cannabis businesses (or roughly 5 percent of the state’s legal cannabis supply chain) until those businesses implement track-and-trace system training and credentialing. The NCBI Cannabis sativa Annotation Release 100 is now live and publicly available.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45